Close
ACHEMA MIDDLE EAST 2026

Webflow Mobile App Launch

WebflowTM is a comprehensive customer support center which provides PCI clients real-time, 24/7 access to a wide range of reports and information regarding the...

Iovance Biotherapeutics Partners with TrakCel for Personalized Patient Product Management

Iovance Biotherapeutics, Inc. and TrakCel Ltd. announced a partnership to build a scheduling and logistics tool that automates the supply chain for Iovance’s adoptive...

More than 96 Percent of Claimants Opt-In to ACTOS Resolution Program;

Takeda Pharmaceutical Company Limited (TSE: 4502) and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc. (collectively “Takeda”), today announced that more than 96 percent of...

ERS 2015: Landmark year for Boehringer Ingelheim’s respiratory portfolio – new data for COPD, IPF and asthma treatments

Head-to-head ENERGITO® study comparing benefits of Spiolto® Respimat® to LABA/ICS therapy in COPD1 and sub-analysis of OTEMTO® 1&2 trials showing quality of life improvementNew...

Bristol-Myers Squibb Prices €1.15 Billion of Senior Notes

Bristol-Myers Squibb Company (NYSE:BMY) announced today that it has agreed to sell €1.15 billion of senior unsecured notes: €575,000,000 in aggregate principal amount of...

Bristol-Myers Squibb Announces Cash Tender Offer For Up to $400 Million Aggregate Principal Amount of its Outstanding Debt Securities

Announcement today that it has commenced a cash tender offer for up to $400 million aggregate principal amount (the “tender cap”) of specified series...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...